GlassScriptPhysician profile
Adrian L Burrowes
NPI 1700822657
$7,449.19
in general payments reported to CMS, 2019-2025
51 companies · $934 in 2025
The $934 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2020: $745 · 2021: $713 · 2022: $1,872 · 2023: $1,106 · 2024: $1,159 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,166 · Education: $32.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,166.19 |
| Education | $32.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,331.73 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $438.28 | 2023-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $386.91 | 2019-2024 | Austedo Xr, Austedo |
| Janssen Pharmaceuticals, INC | $297.55 | 2019-2022 | |
| Astellas Pharma US INC | $278.55 | 2019-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $264.28 | 2019-2024 | |
| Exact Sciences Corporation | $252.67 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Acadia Pharmaceuticals INC | $247.72 | 2019-2025 | Nuplazid |
| Astrazeneca Pharmaceuticals LP | $229.40 | 2019-2022 | |
| Abbvie INC. | $224.92 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Abbott Laboratories | $220.82 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Eisai INC. | $217.05 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $209.05 | 2023-2024 | Gemtesa |
| Neurocrine Biosciences, INC. | $207.18 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $202.06 | 2019-2025 | Xifaxan, Relistor |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $185.43 | 2019-2025 | Evenity, Prolia, Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.48 | 2024 | Ofev, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $163.42 | 2021-2024 | |
| Glaxosmithkline, LLC. | $153.09 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $137.87 | 2019-2023 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Insmed, INC. | $135.91 | 2019-2025 | Arikayce, Brinsupri |
| Lilly USA, LLC | $133.98 | 2019-2025 | Mounjaro |
| Lundbeck LLC | $132.20 | 2023-2025 | Rexulti |
| Gilead Sciences, INC. | $121.21 | 2019 | |
| Sunovion Pharmaceuticals INC. | $118.60 | 2020 | |
| Amarin Pharma, INC. | $111.25 | 2019-2021 | |
| Daiichi Sankyo INC. | $93.82 | 2019-2025 | Injectafer |
| Endo Pharmaceuticals INC. | $83.20 | 2020-2021 | |
| Novo Nordisk INC | $81.48 | 2020-2025 | Ozempic |
| Allergan, INC. | $74.69 | 2019-2020 | |
| Sanofi Pasteur INC. | $63.00 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $50.86 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $44.74 | 2019 | |
| Axsome Therapeutics, INC. | $43.73 | 2025 | Auvelity |
| Vivus LLC | $35.51 | 2021-2024 | Qsymia |
| Phadia US INC. | $25.91 | 2022-2024 | Immunocap |
| Silk Road Medical, INC. | $24.27 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Nestle Healthcare Nutrition INC. | $22.88 | 2023 | |
| Biogen, INC. | $21.98 | 2021 | |
| Smith+Nephew, INC. | $21.46 | 2025 | Collagenase Santyl |
| Urovant Sciences INC | $20.95 | 2022 | |
| Sanofi-Aventis U.S. LLC | $20.80 | 2024 | |
| Corcept Therapeutics | $20.30 | 2024 | Korlym |
| Renalytix Ai, INC. | $19.04 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $16.56 | 2025 | |
| Avanir Pharmaceuticals, INC. | $15.90 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.70 | 2019 | |
| Sun Pharmaceutical Industries INC. | $15.51 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.23 | 2020 | |
| Cashflow Solutions, LLC | $11.75 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Burrowes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.